| Literature DB >> 34901215 |
Hong Meng1, Wu Song2, Sheng Liu2, David Hsi3, Lin-Yuan Wan1, Hui Li1, Shan-Shan Zheng2, Zhi-Wei Wang4, Rong Ren4, Wei-Xian Yang5.
Abstract
Background: There have been no systemic studies about right heart filling pressure and right ventricular (RV) distensibility in patients with chronic thromboembolic pulmonary hypertension (CTEPH). Therefore, we aimed to explore combinations of echocardiographic indices to assess the stages of RV diastolic dysfunction. Methods andEntities:
Keywords: chronic thromboembolic pulmonary artery hypertension; early diastolic strain rate; indexed right atrial area; right heart filling pressure; right ventricular diastolic dysfunction
Year: 2021 PMID: 34901215 PMCID: PMC8660143 DOI: 10.3389/fcvm.2021.755251
Source DB: PubMed Journal: Front Cardiovasc Med ISSN: 2297-055X
Figure 1A six-segment model of the right ventricle was created by the tracking algorithm after manual delineation of the endocardial border. The global longitudinal strain rate (SR) (dotted line) is calculated by averaging the regional peak values. In this patient with chronic thromboembolic pulmonary artery hypertension (CTEPH), the global early diastolic SR is severely depressed (0.27 s−1).
Mean values and SDs of the baseline characteristics of all participants and preoperative general medical records of CTEPH patients.
|
|
|
|
| |
|---|---|---|---|---|
| Age, years | 42.5 ± 8.0 | 47.6 ± 13.6 | 0.052 | |
| Male, no. (%) | 15 (46.9%) | 45 (63.4%) | 0.134 | |
| SBP/DPB, mmHg | 121/72 | 114/70 | 0.329 | |
| BMI | 23.7 ± 2.4 | 23.3 ± 3.4 | 0.608 | |
| BSA | 1.8 ± 0.2 | 1.8 ± 0.2 | 0.234 | |
| Blood glucose | 5.0 ± 0.2 | 4.5 ± 0.6 | ||
| Hemoglobin (g/dL) | 130 ± 5.6 | 140 ± 20 | ||
|
| ||||
| BUN (mmol/L) | 4.5 ± 0.4 | 5.7 ± 1.6 | ||
| Creatinine (mol/L) | 61.8 ± 10.2 | 85.2 ± 16.0 | ||
|
| ||||
| Total bilirubin (mol/L) | 7.5 ± 2.5 | 17.2 ± 9.4 | ||
| Direct bilirubin (mol/L) | 1.4 ± 0.3 | 4.7 ± 3.9 | ||
| NT pro-BNP | 799.0 ± 882.1 | |||
| NYHA | I | 32 (100%) | 0 (0%) | |
| II | 27 (38%) | |||
| III | 42 (59.2%) | |||
| IV | 2 (2.8%) | |||
| 6MWT | ≤ 300 m | 12 (24.5%) | ||
| 300–375 m | 11 (22.4%) | |||
| 375–449.9 m | 17 (34.7%) | |||
| ≥450 m | 32 (100%) | 9 (18.4%) | ||
| GFR | ≥90 ml/min | 32 (100%) | 34 (47.9%) | |
| 60–89 ml/min | 25 (35.2%) | |||
| 30–59 ml/min | 10 (14.1%) | |||
| 15–29 ml/min | 2 (2.8%) | |||
CTEPH, chronic thromboembolic pulmonary hypertension; BMI, body mass index; BSA, body surface area; BUN, blood urea nitrogen; NT pro-BNP, N-terminal prohormone of brain natriuretic peptide; 6MWT, 6-minute walk test; GFR, glomerular filtration rate.
Figure 2Correlations between pulmonary artery systolic pressure (PASP) and early diastolic SR (A) and indexed right atrial (RA) area (B).
Figure 3Receiver operating characteristic (ROC) curve analysis finds the echocardiographic parameters to identify right ventricular diastolic dysfunction based on early diastolic SR, indexed RA area, right ventricular index of myocardial performance (RIMP), and isovolumic relaxation time (IVRT).
Right ventricular systolic and diastolic parameters of normal control participants and CTEPH patients with different right atrial and right ventricular pressures.
|
|
|
|
| |||
|---|---|---|---|---|---|---|
|
|
|
|
| |||
|
|
|
|
|
| ||
| Numbers | 32 | 52 | 19 | 46 | 25 | |
| PASP (mm Hg, by echo) | 21.09 ± 3.09 | 76.06 ± 26.75 | 91.80 ± 22.15[ | 73.98 ± 25.66[ | 92.11 ± 24.60[ | |
| RV EDV (ml, by 3D echo) | 72.07 ± 18.16 | 129.67 ± 54.63 | 157.86 ± 56.58 | 136.63 ± 59.28 | 140.31 ± 52.45 | |
| RV EF (%, by 3D echo) | 56.27 ± 3.13 | 33.89 ± 10.39 | 29.90 ± 9.68 | 33.65 ± 10.68 | 31.27 ± 9.77 | |
| RIMP | 0.28 ± 0.09 | 0.71 ± 0.32 | 0.63 ± 0.17 | 0.66 ± 0.27 | 0.75 ± 0.32 | |
| TVE/A ratio | 1.36 ± 0.25 | 0.97 ± 0.32 | 1.26 ± 0.46 | 0.95 ± 0.33 | 1.21 ± 0.41 | |
| TV annular e' (cm/s) | 11.58 ± 2.47 | 7.26 ± 1.89 | 7.93 ± 3.01 | 7.51 ± 2.09 | 7.44 ± 2.57 | |
| E/e' ratio | 4.94 ± 1.19 | 6.44 ± 2.61 | 7.74 ± 2.63 | 6.44 ± 2.88 | 7.59 ± 1.98 | |
| TV DT (ms) | 262.09 ± 73.83 | 240.20 ± 92.32 | 220.07 ± 67.98 | 245.11 ± 89.86 | 210.94 ± 75.17 | |
| IVRT (ms) | 57.50 ± 18.46 | 122.88 ± 54.17 | 97.66 ± 32.71[ | 112.93 ± 50.53 | 119.29 ± 50.70 | |
| Indexed RA area (cm2/m2) | 6.82 ± 1.10 | 11.36 ± 3.47 | 14.24 ± 4.73[ | 11.67 ± 3.82 | 12.91 ± 4.33 | |
| Early diastolic SR (s−1) | 1.40 ± 0.39 | 0.51 ± 0.29 | 0.65 ± 0.34 | 0.52 ± 0.29 | 0.57 ± 0.33 | |
| Late diastolic SR (s−1) | 1.14 ± 0.32 | 0.94 ± 0.29 | 0.59 ± 0.32[ | 0.84 ± 0.28 | 0.87 ± 0.40 | |
| Mean RA pressure (mm Hg) | 4.37 ± 2.34 | 12.00 ± 3.27 | 5.76 ± 3.9 | 7.61 ± 4.8 | ||
| RV diastolic pressure (mm Hg) | 1.20 ± 5.95 | 3.83 ± 4.06 | −0.53 ± 5.12 | 6.91 ± 2.14 | ||
| RV diastolic pattern1 | Normal | 32 | 8 | 4 | 10 | 2 |
| Stage 1 | 23 | 3 | 22 | 4 | ||
| Stage 2 | 21 | 12(χ2 = 4.89) | 15 | 18 (χ2 = 11.86) | ||
| RV diastolic pattern2 | Normal | 32 | 2 | 2 | 3 | 1 |
| Stage 1 | 22 | 2 | 20 | 4 | ||
| Stage 2 | 28 | 15 (χ2 = 6.71) | 24 | (χ2 =5.36) | ||
CTEPH, chronic thromboembolic pulmonary artery hypertension; RAMP, right atrial mean pressure; RVDP, right ventricular diastolic pressure; PASP, pulmonary artery systolic pressure; 3D echo, three-dimensional echocardiography; RV EDV, right ventricular end-diastolic volume; EF, ejection fraction; RIMP, right ventricular index of myocardial performance; DT, deceleration time; IVRT, isovolumic relaxation time; RA area, right atrial area; SR, strain rate.
RV diastolic pattern1, based on the E/A ratio, E/e′ ratio, and DT.
RV diastolic pattern2, added early diastolic strain rate, indexed right atrial area, RIMP, and IVRT.
In comparison with group 1,
P = 0.0001;
P = 0.001;
P < 0.007;
P < 0.03.
In comparison with group 2,
P = 0.0001;
P = 0.001;
P ≤ 0.03.
In comparison with group 4,
P = 0.0001;
P < 0.01;
P ≤ 0.04.
The relations between the relative factors and the decreased 6MWT distance during follow-up based on logistic regression models, including preoperative pulmonary artery systolic pressure (PASP), mean pulmonary artery pressure (PAP), indexed right atrial area, early diastolic strain rate, right ventricular index of myocardial performance, isovolumic relaxation time, tricuspid regurgitation (TR) degree, the follow-up PASP, and TR degree.
|
|
|
| ||||||
|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
| |
| PASP (mm Hg) | 0.004 | 0.04 | 1.004 | 0.841 | −0.080 | 0.757 | 0.923 | 0.384 |
| PAP (mean, mm Hg) | 0.024 | 0.50 | 1.024 | 0.479 | 0.173 | 1.225 | 1.189 | 0.268 |
| Indexed RA area (cm2/m2) | 0.319 | 5.193 | 1.375 | 0.023 | 3.383 | 3.949 | 1.606 | 0.036 |
| Early diastolic SR (s−1) | 0.649 | 0.266 | 1.913 | 0.606 | 1.830 | 0.946 | 6.235 | 0.331 |
| RIMP | −1.156 | 0.474 | 0.315 | 0.491 | −3.034 | 0.417 | 0.048 | 0.519 |
| IVRT (ms) | −0.219 | 0.456 | 0.993 | 0.50 | 0.004 | 0.026 | 1.004 | 0.872 |
| TR degree | 0.802 | 0.721 | 2.057 | 0.37 | −0.932 | 0.382 | 0.394 | 0.537 |
| TR degree (FU) | 0.975 | −0.997 | 0.369 | 0.324 | 3.891 | 1.105 | 0.323 | 0.293 |
| PASP (FU, mm Hg) | 0.003 | 0.003 | 1.003 | 0.957 | −0.223 | 1.853 | 0.800 | 0.173 |
PASP, pulmonary artery systolic pressure; PAP (mean), pulmonary artery mean pressure; RA area, right atrial area; SR, strain rate; RIMP, right ventricular index of myocardial performance; IVRT, isovolumic relaxation time; TR, tricuspid regurgitation; FU, follow up.